Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-08 Sale |
2020-06-10 4:06 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
2,000 | $30 | $60,002 | 305,116 (Direct) |
View |
| 2020-06-03 Sale |
2020-06-05 7:59 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
1,600 | $30.04 | $48,072 | 531,322 (Direct) |
View |
| 2020-06-03 Sale |
2020-06-05 7:55 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,930 | $30.05 | $178,173 | 8,605,473 (Indirect Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 4:06 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,000 | $29.19 | $2,335,390 | 7,938,783 (Indirect Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 4:06 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
7,200 | $29.36 | $211,401 | 308,716 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 4:05 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
2,585 | $29.37 | $75,912 | 261,683 (Direct) |
View |
| 2020-05-28 Sale |
2020-06-01 5:15 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
2,389,690 | $33.39 | $79,791,749 | 34,510,971 (Indirect) |
View |
| 2020-05-05 Sale |
2020-05-06 8:28 pm |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
1,460 | $30.47 | $44,493 | 162,362 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-06 8:26 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
5,706 | $30.49 | $173,959 | 315,916 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-06 8:21 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
79,600 | $31.02 | $2,469,482 | 8,018,783 (Indirect Direct) |
View |
| 2020-05-01 Sale |
2020-05-05 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,400 | $29.4 | $2,364,085 | 8,098,383 (Indirect Direct) |
View |
| 2020-05-01 Sale |
2020-05-05 06:15 am |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
8,694 | $29.37 | $255,302 | 321,622 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-05 06:13 am |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS See Remarks |
3,905 | $29.52 | $115,267 | 163,822 (Direct) |
View |
| 2020-04-27 Sale |
2020-04-29 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $32.01 | $64,028 | 287,823 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-03 Option Award |
2020-06-05 8:02 pm |
N/A 2030-06-02 |
BridgeBio Pharma Inc. | BBIO | YAU YI CHING Chief Accounting Officer |
52,314 | $0 | 52,314 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 7:59 pm |
N/A 2030-06-02 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks |
224,206 | $0 | 531,322 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 7:57 pm |
N/A 2030-06-02 |
BridgeBio Pharma Inc. | BBIO | Stolz Brian M. Chief Operating Officer |
209,259 | $0 | 209,259 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 7:55 pm |
N/A 2030-06-02 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
672,620 | $0 | 8,605,473 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 7:23 pm |
N/A 2030-06-01 |
BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director |
112,422 | $0 | 112,422 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 7:21 pm |
N/A 2030-06-01 |
BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Chairman of Pharmaceuticals |
112,422 | $0 | 112,422 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 7:19 pm |
N/A 2030-06-01 |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
112,422 | $0 | 112,422 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 7:17 pm |
N/A 2030-06-01 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director 10% Owner |
112,422 | $0 | 112,422 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 7:17 pm |
N/A 2030-06-01 |
BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks |
112,422 | $0 | 112,422 (Direct) |
View |
| 2020-06-02 Option Award |
2020-06-04 7:11 pm |
N/A 2030-06-01 |
BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director |
112,422 | $0 | 112,422 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-03 4:07 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Sinha Uma Chief Scientific Officer |
7,500 | $0 | 7,500 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-27 4:57 pm |
2020-05-19 2029-12-17 |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
18,365 | $0 | 264,268 (Direct) |
View |
| 2020-05-26 Exercise |
2020-05-27 4:57 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
18,365 | $1.05 | 264,268 (Direct) |
View |
| 2020-05-19 Option Award |
2020-05-21 4:31 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | HENDERSON MICHAEL THOMAS Chief Business Officer |
444,106 | $0 | 606,468 (Direct) |
View |
| 2020-05-19 Option Award |
2020-05-21 4:26 pm |
2020-05-19 2027-08-23 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
124,890 | $0 | 124,890 (Direct) |
View |
| 2020-05-19 Option Award |
2020-05-21 4:18 pm |
2020-05-19 2027-11-15 |
BridgeBio Pharma Inc. | BBIO | Sinha Uma Chief Scientific Officer |
109,037 | $0 | 123,037 (Direct) |
View |
| 2020-05-19 Option Award |
2020-05-21 4:06 pm |
2020-05-19 2029-09-17 |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Chairman of Oncology |
49,591 | $0 | 1,311,117 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 4:05 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $0 | 287,823 (Direct) |
View |
| 2020-04-27 Exercise |
2020-04-29 4:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Turtle Cameron See Remarks |
2,000 | $17 | 287,823 (Direct) |
View |